Daiwa Securities Group’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.72M | Buy |
33,875
+5,980
| +21% | +$279K | 0.01% | 676 |
|
|
2025
Q4 | $823K | Sell |
27,895
-3,635
| -12% | -$98.8K | ﹤0.01% | 814 |
|
|
2025
Q3 | $815K | Buy |
31,530
+6,883
| +28% | +$192K | ﹤0.01% | 797 |
|
|
2025
Q2 | $680K | Sell |
24,647
-23,643
| -49% | -$623K | ﹤0.01% | 806 |
|
|
2025
Q1 | $1.37M | Sell |
48,290
-2,975
| -6% | -$106K | 0.01% | 676 |
|
|
2024
Q4 | $2.13M | Sell |
51,265
-18,926
| -27% | -$905K | 0.01% | 579 |
|
|
2024
Q3 | $4.69M | Buy |
70,191
+10,960
| +19% | +$1.01M | 0.02% | 393 |
|
|
2024
Q2 | $7.03M | Buy |
59,231
+5,309
| +10% | +$672K | 0.04% | 270 |
|
|
2024
Q1 | $5.75M | Buy |
53,922
+5,022
| +10% | +$506K | 0.03% | 297 |
|
|
2023
Q4 | $4.86M | Buy |
48,900
+2,476
| +5% | +$208K | 0.03% | 309 |
|
|
2023
Q3 | $4.79M | Buy |
46,424
+5,930
| +15% | +$661K | 0.03% | 283 |
|
|
2023
Q2 | $4.92M | Sell |
40,494
-549
| -1% | -$73.2K | 0.03% | 284 |
|
|
2023
Q1 | $6.3M | Buy |
41,043
+1,645
| +4% | +$271K | 0.04% | 224 |
|
|
2022
Q4 | $7.08M | Buy |
39,398
+713
| +2% | +$117K | 0.05% | 198 |
|
|
2022
Q3 | $4.58M | Buy |
38,685
+1,390
| +4% | +$211K | 0.04% | 261 |
|
|
2022
Q2 | $5.33M | Buy |
37,295
+1,391
| +4% | +$199K | 0.04% | 236 |
|
|
2022
Q1 | $6.18M | Buy |
35,904
+3,336
| +10% | +$562K | 0.04% | 235 |
|
|
2021
Q4 | $8.27M | Buy |
32,568
+2,569
| +9% | +$751K | 0.05% | 202 |
|
|
2021
Q3 | $11.5M | Buy |
29,999
+6,740
| +29% | +$2.49M | 0.08% | 138 |
|
|
2021
Q2 | $5.46M | Buy |
23,259
+1,924
| +9% | +$344K | 0.04% | 222 |
|
|
2021
Q1 | $2.79M | Buy |
21,335
+2,873
| +16% | +$416K | 0.02% | 339 |
|
|
2020
Q4 | $1.93M | Sell |
18,462
-378
| -2% | -$38.2K | 0.01% | 400 |
|
|
2020
Q3 | $1.33M | Buy |
18,840
+16,965
| +905% | +$1.18M | 0.01% | 436 |
|
|
2020
Q2 | $56K | Hold |
1,875
| – | – | ﹤0.01% | 907 |
|
|
2020
Q1 | $56K | Sell |
1,875
-6
| -0.3% | -$138 | ﹤0.01% | 960 |
|
|
2019
Q4 | $37K | Buy |
+1,881
| New | +$33.4K | ﹤0.01% | 979 |
|
Other funds holding MRNA
VCM
VPM
